Beth Hinkle
Senior Director, Nonclinical Safety at The Janssen Pharmaceutical Companies of Johnson & Johnson
- Role
- Senior Director, Nonclinical Safety at Johnson & Johnson Innovative Medicine
- Location
- San Diego, CA, US
- LinkedIn followers
- 500 followers
About Beth Hinkle
Toxicologist providing nonclinical safety expertise for small molecule and biotechnology-derived therapeutic drug candidates including small molecules, monoclonal antibodies, recombinant proteins, BiTEs, antibody drug conjugates, and Fc-enhanced antibodies. Manager, mentor, and leader in developing safety strategies for drug development programs spanning the portfolio from discovery to registration.
Experience
Senior Director, Nonclinical Safety
Johnson & Johnson Innovative Medicine
Sep 2019 — Present · CA
Early Therapeutic Area Lead, Immunology• Mentor and advise NCS Leads in developing the toxicology strategy for Immunology projects covering multiple modalities from the nomination of a target through candidate selection • Partner with Immunology TA leaders to ensure alignment on project goals, issues, and prioritization for the portfolio. Maintain expertise in the represented TA, with a perspective on the evolving internal and external landscape and from different stakeholder views (indications, science of target pathways, diligence, external competitive landscape, regulatory impacts, etc.). • Represent NCS in portfolio governance and business development forums in the Discovery Immunology space
Education
UCSB
Doctor of Philosophy (Ph.D.)
University of Denver
Bachelor of Arts (B.A.)
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.